Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2017, Vol. 37 Issue (10): 118-125    DOI: 10.13523/j.cb.20171016
    
Expression and Optimization Strategy of Recombinant Proteins in Chlamydomonas Chloroplast
LIN You-hong, CHENG Xia-ying, YAN Yi-wen, LIANG Zong-suo, YANG Zong-qi
College of Life Science, Zhejiang Sci-Tech University, Hangzhou 310018, China
Download: HTML   PDF(460KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  In recent years, transgenic technology has developed rapidly, and it has found an increasingly wide utilization in medical and industrial fields. Drug therapy which based on recombinant proteins is the fastest growing technology in pharmaceutical production areas. Their high specificity and low side effect makes treatment efficiency very prominent. However, the complexity of recombinant proteins synthesis also bring production to a certain restrictions. In order to promote the application of these recombinant proteins, expression systems that fit it and strategies that can facilitate it were explored. Compared to other traditional production systems, the research found that Chlamydomonas chloroplast as a bioreactor has several incomparable advantages, it can achieve more rapidly, high yields, lower cost on the production of recombinant proteins, and can be grown in artificial medium and artificially controlled conditions, which reduce the risk of contamination. Through the application of some new techniques, synthesis of recombinant proteins has also been improved. Therefore,Chlamydomonas chloroplast will play a great role in the field of biotechnology in the future as a recombinant proteins with pharmaceutical relevance bioreactor. The expression of recombinant proteins and the optimization strategies in Chlamydomonas chloroplast were reviewed.

Key wordsAlgal chloroplast      Optimization strategy      Bioreactor      Recombinant proteins     
Received: 17 April 2017      Published: 25 October 2017
ZTFLH:  Q819  
Cite this article:

LIN You-hong, CHENG Xia-ying, YAN Yi-wen, LIANG Zong-suo, YANG Zong-qi. Expression and Optimization Strategy of Recombinant Proteins in Chlamydomonas Chloroplast. China Biotechnology, 2017, 37(10): 118-125.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20171016     OR     https://manu60.magtech.com.cn/biotech/Y2017/V37/I10/118

[1]   Mayfield S P, Manuell A L, Chen S, et al. Chlamydomonas reinhardtii chloroplasts as protein factories. Current Opinion in Biotechnology, 2007, 18(2):126-133.
[2]   Specht E, Miyake-Stoner S, Mayfield S. Micro-algae come of age as a platform for recombinant protein production. Biotechnology Letters, 2010, 32(10):1373-1383.
[3]   Bock R. Plastid biotechnology:prospects for herbicide and insect resistance, metabolic engineering and molecular farming. Current Opinion in Biotechnology, 2007, 18(2):100-106.
[4]   韩四海, 胡章立, 王潮岗. 外源基因在莱茵衣藻叶绿体中的表达. 生物技术通报, 2007, (1):89-94. Han S H, Hu Z L, Wang C G. Exppession of foreign genes in Chlamydomonas reinhardtii chloroplast.Biotechnology Bulletin, 2007, 1:89-94.
[5]   Rasala B A, Mayfield S P. Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses. Photosynthesis Research, 2015, 123(3):227-239.
[6]   Rochaix J D. Chlamydomonas reinhardtii as the photosynthetic yeast. Annual Review of Genetics, 1995, 29(1):209-230.
[7]   Maul J E, Lilly J W, Cui L, et al. The Chlamydomonas reinhardtii plastid chromosome:islands of genes in a sea of repeats. Plant Cell, 2002, 14(11):2659-2679.
[8]   Goldschmidtclermont M. Transgenic expression of aminoglycoside adenine transferase in the chloroplast:a selectable marker of site-directed transformation of Chlamydomonas. Nucleic Acids Research, 1991, 19(15):4083-4089.
[9]   Minko I, Holloway S P, Nikaido S, et al. Renilla luciferase as a vital reporter for chloroplast gene expression in Chlamydomonas. Molecular Genetics and Genomics, 1999, 262(3):421-425.
[10]   Franklin S, Ngo B, Efuet E, et al. Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. Plant Journal, 2002, 30(6):733-744.
[11]   Sun M, Qian K, Su N, et al. Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnology Letters, 2003, 25(13):1087-1092.
[12]   Mayfield S P, Schultz J. Development of a luciferase reporter gene, luxCt, for Chlamydomonas reinhardtii chloroplast. Plant Journal, 2004, 37(3):449-458.
[13]   苏忠亮. 一种抗肿瘤蛋白基因在衣藻叶绿体中的重组与表达. 浙江大学, 2005. Su Z L. The Recombination and heterogeneous expression of an anti-tumor gene in the chloroplast of Chlamydomonas reinhardtii.Hangzhou:Zhejiang University, 2005.
[14]   杨宗岐, 李轶女, 张志芳, 等. 来源于 Pyrococcus furiosus的耐高温 α-淀粉酶基因在衣藻叶绿体中的表达. 生物工程学报, 2006, 22(4):545-549. Yang Z Q, Li Y N, Zhang Z F,et al. Expression of the gene coding for a thermostable α-amylase from Pyrococcus furious in Chlamydomonas reinhardtii chloroplast.Chinese Journal of Biotechnology, 2006, 22(4):545-549.
[15]   杨宗岐, 李轶女, 陈凤, 等. 人可溶性TRAIL蛋白在衣藻叶绿体中的表达. 科学通报, 2006, 51(12):1400-1405. Yang Z Q, Li Y N, Chen F, et al. Expression of human soluble TRAIL protein in Chlamydomonas reinhardtii chloroplast. Chinese Science Bulletin, 2006, 51(12):1400-1405.
[16]   赵雅坤, 史贤明, 张忠明. 人白细胞介素4在衣藻叶绿体中的高效转化及表达. 华中农业大学学报, 2006, 25(2):110-116. Zhao Y K, Shi X M, Zhang Z M. Efficient transformation and expression of human interleukin-4 in Chlamydomonas reinhardtii chloroplast.Journal of Huazhong Agricultural University, 2006, 25(2):110-116.
[17]   Wang X, Brandsma M, Tremblay R, et al. A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnology, 2008, 8(1):87.
[18]   刘国宪. 狂犬病G,N抗原基因在衣藻叶绿体中的定点重组和表达. 北京:首都师范大学, 2009. Liu G X. Site-specific recombination and expression of rabies virus G and N antigentic genes in chloroplast of Chlamydomonas reinhardtii. Beijing:Capital Normal University, 2009.
[19]   Gregory J A, Li F, Tomosada L M, et al. Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission. PLoS One, 2012, 7(5):e37179.
[20]   Tran M, Van C, Barrera D J, et al. Production of unique immunotoxin cancer therapeutics in algal chloroplasts. Proceedings of the National Academy of Sciences, 2012, 110(1):15-22.
[21]   Gregory J A, Topol A B, Doerner D Z, et al. Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. Applied & Environmental Microbiology, 2013, 79(13):3917-3925.
[22]   Demurtas O C, Massa S, Ferrante P, et al. A Chlamydomonas-derived human papillomavirus 16 E7 vaccine induces specific tumor protection. PloS One, 2013, 8(4):e61473.
[23]   Barrera D J, Rosenberg J N, Chiu J G, et al. Algal chloroplast produced camelid VHH antitoxins are capable of neutralizing botulinum neurotoxin. Plant Biotechnology Journal, 2015, 13(1):117-124.
[24]   Ochoa-Méndez C E, Lara-Hernández I, González L M, et al. Bioactivity of an antihypertensive peptide expressed in Chlamydomonas reinhardtii. Journal of Biotechnology, 2016, 240:76-84.
[25]   Beltrán-López J I, Romero-Maldonado A, Monreal-Escalante E,et al. Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies. Plant Cell Reports, 2016, 35(5):1133-1141.
[26]   Chen H C, Melis A. Marker-free genetic engineering of the chloroplast in the green microalga Chlamydomonas reinhardtii. Plant Biotechnology Journal, 2013, 11(7):818-828.
[27]   Gangl D, Zedler J A, W?odarczyk A, et al. Expression and membrane-targeting of an active plant cytochrome P450 in the chloroplast of the green alga Chlamydomonas reinhardtii. Phytochemistry, 2015, 110:22-28.
[28]   Almaraz-Delgado A L, Flores-Uribe J, Pérez-Espa?a V H, et al. Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii. AMB Express, 2014, 4:57.
[29]   Bertalan I, Munder M C, Wei? C, et al. A rapid, modular and marker-free chloroplast expression system for the green alga Chlamydomonas reinhardtii. Journal of Biotechnology, 2015, 195:60-66.
[30]   Manuell A L, Beligni M V, Elder J H, et al. Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnology Journal, 2007, 5(3):402-412.
[31]   Muto M, Henry R E, Mayfield S P. Accumulation and processing of a recombinant protein designed as a cleavable fusion to the endogenous Rubisco LSU protein in Chlamydomonas chloroplast. BMC Biotechnology, 2009, 9:26.
[32]   Ishikura K, Takaoka Y, Kato K, et al. Expression of a foreign gene in Chlamydomonas reinhardtii chloroplast. J Biosci Bioeng, 1999, 87(3):307-314.
[33]   Barnes D, Franklin S, Schultz J, et al. Contribution of 5'-and 3'-untranslated regions of plastid mRNAs to the expression of Chlamydomonas reinhardtii chloroplast genes. Molecular Genetics and Genomics, 2005, 274(6):625-636.
[34]   Kasai S, Yoshimura S, Ishikura K, et al. Effect of coding regions on chloroplast gene expression in Chlamydomonas reinhardtii. J Biosci Bioeng, 2003, 95(3):276-282.
[35]   Surzycki R, Greenham K, Kitayama K, et al. Factors effecting expression of vaccines in microalgae. Biologicals, 2009, 37(3):133-138.
[36]   Wu S, Xu L, Huang R, et al. Improved biohydrogen production with an expression of codon-optimized hemH and lba genes in the chloroplast of Chlamydomonas reinhardtii. Bioresource Technology, 2011, 102(3):2610-2616.
[37]   Johnson E A. Monitoring foreign gene incorporation into the plastome of Chlamydomonas reinhardtii by multiplex qPCR. Photosynthesis Research, 2013, 115(1):81-87.
[38]   Zedler J A, Gangl D, Guerra T, et al. Pilot-scale cultivation of wall-deficient transgenic Chlamydomonas reinhardtii strains expressing recombinant proteins in the chloroplast. Applied Microbiology and Biotechnology, 2016, 100(16):7061-7070.
[1] WANG Hui-lin,ZHOU Kai-qiang,ZHU Hong-yu,WANG Li-jing,YANG Zhong-fan,XU Ming-bo,CAO Rong-yue. Research Progress of Human Coagulation Factor VII and the Recombinant Expression Systems[J]. China Biotechnology, 2021, 41(2/3): 129-137.
[2] JIN Lu,ZHOU Hang,CAO Yun,WANG Zhou-shou,CAO Rong-yue. Research on Applications of High-Throughput Perfusion Models in Bioprocessing Development[J]. China Biotechnology, 2020, 40(8): 63-73.
[3] LIANG Zhen-xin,LIU Fang,ZHANG wei,LIU Qing-you,LI Li. The Preparation and Validation of p185 erb B2 Human-mouse Chimeric Antibody ChAb26 Transgenic Mice Mammary Gl and Bioreactor[J]. China Biotechnology, 2019, 39(8): 40-51.
[4] Yu-lei GUO,Liang TANG,Rui-qiang SUN,You LI,Yi-jun CHEN. High-Throughput Micro Bioreactor Development for Biopharmaceuticals[J]. China Biotechnology, 2018, 38(8): 69-75.
[5] Ya-fang LI,Ying-hui ZHAO,Sai-bao LIU,Wei WANG,Wei-jun ZENG,Jin-quan WANG,Hong-yan CHEN,Qing-wen MENG. Chicken OV Promoter Expressed HA to Protect Chickens from Lethal Challenge of AIV[J]. China Biotechnology, 2018, 38(7): 67-74.
[6] Jing-jing SUN,Wei-wei ZHOU,Lei-ming ZHOU,Qiao-hui ZHAO,Gui-lin LI. Advance in Large-Scale Culture of Hybridoma Cells in Vitro[J]. China Biotechnology, 2018, 38(10): 82-89.
[7] LIU Ting-ting, LIANG Zi-qiang, LIANG Shi-ke, GUO Ji-xing, WANG Fang-hai. Research Advances of Producing Spider Silk by Biotechnology[J]. China Biotechnology, 2016, 36(5): 132-137.
[8] ZHAO Hui-cun. Research and Development Trend of Biological Reactor Technology Based on Patent Visualization[J]. China Biotechnology, 2016, 36(1): 115-121.
[9] ZHANG Dan-feng, YU Zi-qing, WU Suo-wei, RAO Li-qun, WAN Xiang-yuan. Progress of Plant as Bioreactor in Molecular Pharming[J]. China Biotechnology, 2016, 36(1): 86-94.
[10] SHEN Lan, ZHOU Ai-dong, WU Xiao-qin . Characteristics and Prospects of Different Types of Bioreactors Used for Plant Cell Culture[J]. China Biotechnology, 2015, 35(8): 109-115.
[11] LI Zhi-li, YI Xiao-ping, CHU Ju, ZHUANG Ying-ping, ZHANG Si-liang. A Microcarrier Cell Culture Process for propagating Porcine Parvovirus in PK-15 Cells[J]. China Biotechnology, 2015, 35(7): 62-67.
[12] LIANG Zhen-xin, YIN Fu-qiang, LIU Qing-you, LI Li. Progress and Technology in Mammary Gland Bioreactor of Transgenic Animals[J]. China Biotechnology, 2015, 35(2): 92-98.
[13] ZHANG Si-min, GAO Yue, FANG Yu-dan, ZHANG Jin-mai, ZHANG Jin-zhi. Construction of Mammary Gland-specific and Effective Expression Vector for Mammary Gland Bioreactor[J]. China Biotechnology, 2014, 34(7): 49-55.
[14] LIN Mei-ling, TANG Yin, ZHANG Ming, YI Xiao-ping, HUANG Ming-zhi. Bioprocess Optimization for Recombinant Herpes Simplex Virus type Ⅱ Vaccine Production Based Cell Microcarrier Suspention Culture[J]. China Biotechnology, 2014, 34(3): 68-78.
[15] LEI Xue-qing, LU Zhe, GAO Bao-yan, ZHANG Wen-yuan, LI Ai-fen, ZHANG Cheng-wu. The Growth and Lipids Accumulation Pattern of Oleaginous Green Microalga Scenedesmus acuminatus Large Volume Cultured in Flat Panel Photobioreactor[J]. China Biotechnology, 2014, 34(11): 91-99.